PI-LBA03 TESTOSTERONE THERAPY AND PROSTATE CANCER RISK

MLA

Yasin Folkvaljon, et al. “Pi-Lba03 Testosterone Therapy and Prostate Cancer Risk.” Journal of Urology, vol. 195, Apr. 2016. EBSCOhost, https://doi.org/10.1016/j.juro.2016.03.125.

APA

Yasin Folkvaljon, Joseph P. Alukal, Pär Stattin, Mats Lambe, Stacy Loeb, & Jan-Erik Damber. (2016). Pi-Lba03 Testosterone Therapy and Prostate Cancer Risk. Journal of Urology, 195. https://doi.org/10.1016/j.juro.2016.03.125

Chicago

Yasin Folkvaljon, Joseph P. Alukal, Pär Stattin, Mats Lambe, Stacy Loeb, and Jan-Erik Damber. 2016. “Pi-Lba03 Testosterone Therapy and Prostate Cancer Risk.” Journal of Urology 195 (April). doi:10.1016/j.juro.2016.03.125.